Johnson & Johnson
USUSDJohnson & Johnson (MX:JNJ) — Biotechnology: Pharmaceutical Preparations. Število borz, na katerih se trgujejo delnice družbe: 3. Na tej strani — cena in graf, dividende, največji imetniki in zgodovina števila delnic.
O Podjetju
- Spletna Stran
- jnj.com
- Odnosi z Vlagatelji
- investor.jnj.com/overview/default.aspx
- Sektor
- Health Care · Biotechnology: Pharmaceutical Preparations
- Sedež
- New Brunswick, United States
- Izvršni Direktor
- Joaquin Duato
- Zaposleni
- 136 400
- Ustanovljena
- 1886
- Na Borzi od
- 29.05.2003 (MX:JNJ)
- Delnice v Obtoku
- Prosto Prenosljive Delnice
- 2.41 mrd.
- Tržna Kapitalizacija
- 655.37 mrd. USD
- Notranje Osebe
- 0.05%
- Institucionalni Vlagatelji
- 76.73%
- Panoga (SIC)
- Pharmaceutical Preparations
- Pravna Oblika
- XSNP
- ISIN
- US4781601046
- LEI
- 549300G0CFPGEF6X2043
- P/E
- 40.6
- Delež Izplačila
- 60.0%
- FCF
- 22.2 mrd. USD
- Izplačilo / FCF
- 57%
- Dolg
- 49.0 mrd. USD1.3 let FCF
- Dividendni Staž
- 56+ let
- Dobički, FCF in izplačane dividende — za 12 mesecev do 28.06.2026 (najnovejše poročilo podjetja).
- NAV
Opis
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Dividende
Johnson & Johnson (JNJ) izplačuje dividende četrtletno. Na leto (12 mesecev do in vključno z najnovejšim napovedanim plačilom): 5.32 USD na delnico (plačila: 4). To je približno 2.11% trenutne cene delnice. Naslednji datum ex-dividende je 24.11.2026: 1.34 USD na delnico, izplačilo 08.12.2026. Leta neprekinjenih dividend: 56.
| Ex-Datum | Izplačilo | Znesek | % | Vrsta | Oznaka |
|---|---|---|---|---|---|
| 2026-11-24 napovedano | 2026-12-08 | 1.3400 USD | 0.5/2.1 % | četrtletno | US:JNJ |
| 2026-08-25 | 2026-09-08 | 1.3400 USD | 0.5/1.9 % | četrtletno | US:JNJ |
| 2026-05-26 | 2026-06-09 | 1.3400 USD | 0.6/2.2 % | četrtletno | US:JNJ |
| 2026-02-24 | 2026-03-10 | 1.3000 USD | 0.5/2.1 % | četrtletno | US:JNJ |
| 2025-11-25 | 2025-12-09 | 1.3000 USD | 0.6/2.5 % | četrtletno | US:JNJ |
| 2025-08-26 | 2025-09-09 | 1.3000 USD | 0.7/2.8 % | četrtletno | US:JNJ |
| 2025-05-27 | 2025-06-10 | 1.3000 USD | 0.9/3.3 % | četrtletno | US:JNJ |
| 2025-02-18 | 2025-03-04 | 1.2400 USD | 0.8/3.2 % | četrtletno | US:JNJ |
| 2024-11-26 | 2024-12-10 | 1.2400 USD | 0.8/3.2 % | četrtletno | US:JNJ |
| 2024-08-27 | 2024-09-10 | 1.2400 USD | 0.5/1.9 % | četrtletno | US:JNJ |
| 2024-05-20 | 2024-06-04 | 1.2400 USD | 0.5/1.9 % | četrtletno | US:JNJ |
| 2024-02-16 | 2024-03-05 | 1.1900 USD | 0.5/1.9 % | četrtletno | US:JNJ |
| 2023-11-20 | 2023-12-05 | 1.1900 USD | 0.5/1.9 % | četrtletno | US:JNJ |
| 2023-08-25 | 2023-09-07 | 1.1900 USD | 0.5/1.8 % | četrtletno | US:JNJ |
| 2023-05-22 | 2023-06-06 | 1.1900 USD | 0.5/1.8 % | četrtletno | US:JNJ |
| 2023-02-17 | 2023-03-07 | 1.1300 USD | 0.4/1.8 % | četrtletno | US:JNJ |
| 2022-11-21 | 2022-12-06 | 1.1300 USD | 0.4/1.8 % | četrtletno | US:JNJ |
| 2022-08-22 | 2022-09-06 | 1.1300 USD | 0.4/1.7 % | četrtletno | US:JNJ |
| 2022-05-23 | 2022-06-07 | 1.1300 USD | 0.4/1.3 % | četrtletno | US:JNJ |
| 2022-02-18 | 2022-03-08 | 1.0600 USD | 0.4/0.8 % | četrtletno | US:JNJ |
| 2021-11-22 | 2021-12-07 | 1.0600 USD | 0.4/0.4 % | četrtletno | US:JNJ |
Novice Ta Teden
Sporočila za javnost s spletne strani za vlagatelje podjetja, ki se dnevno posodabljajo. Povezave vodijo na spletno stran podjetja. Naslovi so v izvirnem jeziku, kot na spletni strani podjetja.
Največji Imetniki
| Imetnik | Delež | Delnice | Datum Poročila |
|---|---|---|---|
| BlackRock | 8.8% | 212.1 mio. | 2026-06-30 |
| Vanguard Capital Managem… | 6.52% | 157.23 mio. | 2026-06-30 |
| State Street Corporation | 5.55% | 133.78 mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.17% | 76.42 mio. | 2026-06-30 |
| Vanguard Portfolio Manag… | 2.67% | 64.37 mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.59% | 62.38 mio. | 2026-06-30 |
| Geode Capital Management… | 2.45% | 59.09 mio. | 2026-06-30 |
| JPMORGAN CHASE & CO | 2.42% | 58.3 mio. | 2026-06-30 |
| Morgan Stanley | 1.86% | 44.81 mio. | 2026-06-30 |
| iShares Trust-iShares Co… | 1.35% | 32.48 mio. | 2026-07-31 |
| NORGES BANK | 1.32% | 31.83 mio. | 2026-06-30 |
| State Farm Mutual Automo… | 1.31% | 31.59 mio. | 2026-06-30 |
| Fidelity Concord Street… | 1.29% | 31.13 mio. | 2026-07-31 |
| SPDR S&P 500 ETF TRUST-S… | 1.22% | 29.45 mio. | 2026-08-31 |
| Northern Trust Corporati… | 1.19% | 28.79 mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 0.95% | 22.91 mio. | 2026-06-30 |
| SELECT SECTOR SPDR TRT-S… | 0.72% | 17.3 mio. | 2026-08-31 |
| VANGUARD SPECIALIZED FUN… | 0.56% | 13.53 mio. | 2026-04-30 |
| VANGUARD INSTITUTIONAL I… | 0.54% | 13.07 mio. | 2026-06-30 |
| VANGUARD WHITEHALL FUNDS… | 0.39% | 9.48 mio. | 2026-04-30 |
| DUATO JOAQUIN BOIX (Chie… | ≈0.01% | 307 837 | 2026-08-13 |
| TAUBERT JENNIFER L (Offi… | ≈0.01% | 194 451 | 2026-08-17 |
| WENGEL KATHRYN E (Chief… | ≈0% | 114 659 | 2026-06-11 |
| WOLK JOSEPH J (Chief Fin… | ≈0% | 85 008 | 2026-02-17 |
| SCHMID TIMOTHY (Officer) | ≈0% | 26 251 | 2026-09-02 |
| SWANSON JAMES D (Chief T… | ≈0% | 25 698 | 2026-02-17 |
| REED JOHN C (Officer) | ≈0% | 24 911 | 2026-05-01 |
| DECKER ROBERT J (Officer… | ≈0% | 24 462 | 2026-02-27 |
| BROADHURST VANESSA (Offi… | ≈0% | 23 003 | 2026-07-20 |
| MULHOLLAND KRISTEN (Offi… | ≈0% | 19 830 | 2026-02-13 |
| The Vanguard Group | — | — | — |
